Michael Thomas Henderson is Chief Executive Officer of Apogee Therapeutics Inc.
Person profile
Roles
Apogee Therapeutics
Chief Executive Officer
Spyre Therapeutics
Director
Address
Palo Alto, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Apogee Therapeutics, Inc.
20 Dec 23
3/A
Apogee Therapeutics, Inc.
17 Jul 23
3
Apogee Therapeutics, Inc.
13 Jul 23
3
Aeglea BioTherapeutics, Inc.
30 Jun 23
3
ARYA Sciences Acquisition Corp IV
25 Feb 21
4
BridgeBio Pharma, Inc.
17 Dec 20
4
BridgeBio Pharma, Inc.
2 Dec 20
4
BridgeBio Pharma, Inc.
2 Dec 20
4
BridgeBio Pharma, Inc.
18 Nov 20
4
BridgeBio Pharma, Inc.
3 Nov 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Dec 23 | APGE Apogee Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 22.86 | 398,512 | 9.11 mm | 398,512 |